Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanism Exploration of General Anesthesia-Induced Altered Consciousness
NCT07836205Phase 4Not yet recruiting
- Sponsor
- Beijing Chaoyang Hospital
- Start
- Sep 2026
- Primary completion
- Sep 2028
- Countries
- 1
01
Overview
Phase 4 trial of propofol injection (veterinary), remimazolam, esketamine and dexmedetomidine in Altered Level of Consciousness (ALOC) (4 arms), sponsored by Beijing Chaoyang Hospital. Primary endpoints: Changes in Resting-State Quantitative EEG Measures Across Behavioral Responsiveness States and Changes in Auditory-Evoked ERP and Time-Frequency EEG Measures Across Behavioral Responsiveness States. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
propofol injection (veterinary)remimazolamesketaminedexmedetomidine
03
Conditions
Altered Level of Consciousness (ALOC)
Beyond the preview
Go deeper on NCT07836205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07836205.